Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma

Part of paid clinical trials in Elkridge, Maryland.

Sponsor
Select Eye Care
Study ID
NCT07147647
Status
Recruiting
Apply to this trial

Conditions

  • Primary Open Angle Glaucoma (POAG)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Direct Selective Laser Trabeculoplasty — DEVICE
    DSLT using the Belkin Vision Eagle Device

Study Details

The goal of this clinical trial is to to evaluate how well Direct Selective Laser Trabeculoplasty (DSLT) lowers eye pressure in eyes of adult, non-Caucasian participants with primary open angle glaucoma. The main question it aims to answer is: What is the washed out eye pressure (eye pressure when not on any glaucoma medications) of participants 6 months after the Direct Selective Laser Trabeculoplasty (DSLT) procedure compared to the washed out eye pressure of participants prior to the DSLT procedure. Participants will: Undergo the DSLT procedure in one or both eyes and visit the clinic 1 month, 3 months, and 6 months after the procedure to have their vision and eye pressure measured.

Key Dates

Start date
Jul 16, 2025
Status verified
Aug 2025
Primary completion
Oct 31, 2026
Completion
Oct 31, 2026

Study Design

Enrollment
60 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Direct Selective Laser Trabeculoplasty

Primary Outcome Measure

IOP reduction at 6 months washed out post-DSLT compared with washed out baseline IOP. [ Time Frame: 6 Months post-DSLT ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Select Eye CareElkridgeMaryland21075
Research Coordinator
[email protected]
410-821-6400

Find similar trials in Elkridge, MD

By research site
Select Eye Care· Elkridge, MD

Related Studies